XML 95 R41.htm IDEA: XBRL DOCUMENT v3.25.0.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 28, 2024
Accounting Policies [Abstract]  
Schedule of Fair Value, Assets Measured on Recurring Basis
The following tables represent the Company’s financial assets, measured at fair value on a recurring basis at December 28, 2024:
Fair Value Measurement Hierarchy
(in millions)Total Carrying
Value
Level 1Level 2Level 3
Assets
Cash and cash equivalents$101.0 $101.0 $— $— 
Money market funds76.6 76.6 — — 
Pension assets:
Cash and cash equivalents(1.3)
(1)
(1.3)— — 
Equity securities9.3 9.3 — — 
Debt securities9.6 9.6 — — 
Real estate funds3.6 — 3.6 — 
Alternative investments1.4 — 1.4 — 
Other0.2 — 0.2 — 
Equity securities1.3 1.3 — — 
Derivative instruments - cash flow hedges(2)
6.8 6.8 — — 
Derivative instruments - warrants0.7 0.7 — — 
Total assets$209.2 $204.0 $5.2 $— 
Liabilities
Derivative instruments - cash flow hedge$0.1 $0.1 $— $— 
Pension benefit obligation31.8 31.8 — — 
Total liabilities$31.9 $31.9 $— $— 
______________
(1)     Due to the timing of a cash transfer, there was a payable as of December 28, 2024, resulting in a negative allocation as of year end.
(2)    Includes accrued interest.
The following tables represent the Company’s financial assets, measured at fair value on a recurring basis at December 30, 2023:
Fair Value Measurement Hierarchy
(in millions)Total Carrying
Value
Level 1Level 2Level 3
Assets
Cash and cash equivalents$87.0 $87.0 $— $— 
Money market funds76.0 76.0 — — 
Pension assets:
      Cash and cash equivalents(1.2)
(1)
(1.2)— — 
      Equity securities 8.1 8.1 — — 
      Debt securities10.7 9.9 0.8 — 
      Real estate funds3.1 — 3.1 — 
      Alternative investments1.9 — 1.9 — 
      Other0.5 — 0.5 — 
Equity securities1.7 1.7 — — 
Derivative instruments - cash flow hedges11.6 11.6 — — 
Derivative instruments - warrants1.0 1.0 — — 
Total assets$200.4 $194.1 $6.3 $— 
Liabilities
Derivative instruments - cash flow hedge(2)
$3.6 $3.6 $— $— 
Pension benefit obligation32.6 32.6 — — 
Total liabilities$36.2 $36.2 $— $— 
______________
(1)     Due to the timing of a cash transfer, there was a payable as of December 30, 2023, resulting in a negative allocation as of year end.
(2)    Includes accrued interest.
Schedule of Property and Equipment
Property and equipment are stated at cost. Depreciation is calculated using the straight-line method over estimated useful lives as follows:
Useful Lives
Buildings and building improvements
7 to 39 years
Computer equipment and software
2 to 12 years
Demonstration units
2 to 3 years
Furniture and office equipment
2 to 15 years
Leasehold improvementsLesser of useful life or term of lease
Machinery, equipment and tooling
3 to 20 years
Operating lease assetsLesser of useful life or term of lease
Transportation, vehicles and other
1 to 20 years
Property and equipment, net, consists of the following:
(in millions)December 28,
2024
December 30,
2023
Machinery, equipment and tooling$180.2 $169.7 
Building and building improvements150.3 151.0 
Operating lease assets148.6 92.2 
Land(1)
54.3 66.2 
Computer equipment and software44.4 45.5 
Leasehold improvements40.8 37.5 
Construction-in-progress (CIP)(2)
30.6 59.2 
Furniture and office equipment17.5 20.4 
Demonstration units10.9 11.1 
Transportation, vehicles and other(3)(4)
0.2 34.0 
Total property and equipment
677.8 686.8 
Accumulated depreciation(296.2)(262.4)
Property and equipment, net
$381.6 $424.4 
______________
(1)    At March 30, 2024, property, plant and equipment, net, excluded $11.4 million of idle undeveloped land held outside of the U.S., which was classified as held for sale within the healthcare segment. In May 2024, the Company completed the sale of the land, resulting in a gain of $0.9 million, which was recorded net of transaction costs, foreign currency translation and cumulative translation adjustment.
(2)    In December 2024, in connection with the strategic realignment initiative, the Company recorded a charge of approximately $16.0 million related to a reduction of capitalized costs included in the CIP balance for the property in Vancouver, British Columbia, which was recorded to selling, general and administrative expenses.
(3)    During the three months ended September 28, 2024, the Company reduced its fleet of vehicles for use primarily by field sales representatives. The proceeds from the sale of the vehicles were $2.0 million.
(4)    In October 2024, the Company grounded the corporate aircraft and started exploring disposition strategies. In December 2024, the Company entered into an letter of intent to sell the aircraft, and classified the asset as held for sale within the healthcare segment as of December 28, 2024. On January 29, 2025, the Company completed the sale of the corporate aircraft for $19.5 million.
Schedule of Changes in Product Warranty Accrual
Changes in the product warranty accrual were as follows:
Year Ended
(in millions)December 28,
2024
December 30,
2023
December 31,
2022
Product warranty accrual, beginning of period$8.6 $10.6 $2.5 
Increase related to acquisition, net of reserve— — 8.4 
Accrual for warranties issued9.1 7.8 1.8 
Changes in pre-existing warranties (including changes in estimates)(5.4)(7.5)4.7 
Settlements made(3.1)(2.3)(6.8)
Product warranty accrual, end of period$9.2 $8.6 $10.6 
Schedule of Reconciliation of Basic and Diluted Net Income Per Share
A computation of basic and diluted net (loss) income per share is as follows:
Year Ended
(in millions, except per share amounts)December 28,
2024
December 30,
2023
December 31,
2022
Net (loss) income$(304.9)$81.5 $143.5 
Basic net (loss) income per share:
Weighted-average shares outstanding - basic53.3 52.8 53.6 
Net (loss) income per basic share$(5.72)$1.54 $2.68 
Diluted net (loss) income per share:
Weighted-average shares outstanding - basic53.3 52.8 53.6 
Diluted share equivalents: stock options, RSUs and PSUs— 1.3 1.6 
Weighted-average shares outstanding - diluted53.3 54.1 55.2 
Net (loss) income per diluted share$(5.72)$1.51 $2.60 
Schedule of Supplemental Cash Flow Information
Supplemental cash flow information includes the following:
Year Ended
(in millions)December 28,
2024
December 30,
2023
December 31,
2022
Cash paid during the year for:
Interest expense
$39.1 $51.0 $23.0 
Income taxes
41.9 54.4 87.3 
Operating lease liabilities
24.6 22.4 17.2 
Non-cash operating activities:
ROU assets obtained in exchange for lease liabilities$28.6 $16.3 $— 
Non-cash investing activities:
Unpaid purchases of property and equipment$0.7 $0.2 $3.8 
Non-cash financing activities:
       Unsettled common stock proceeds from option exercises$0.1 $— $— 
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents
$177.6 $163.0 $202.9 
Restricted cash
3.8 5.2 6.7 
Total cash, cash equivalents and restricted cash shown in the statement of cash flows
$181.4 $168.2 $209.6